As a consequence of the listing on the Nasdaq Global Select market, we are subject to additional U.S. regulatory requirements, including U.S. securities laws and the U.S. Foreign Corrupt Practices Act, and may become more exposed to U.S. class actions Genmab has a Code of Business Conduct and Ethics setting high ethical standards for the employees and the Board of Directors.